Bioequivalence Study of Spironolactone Tablets in Healthy Subjects
Phase 1
Completed
- Conditions
- Bioequivalence Study
- Interventions
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- SPH Sine Pharmaceutical Laboratories Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT06579053
- Locations
- 🇨🇳
Shanghai Xuhui Central Hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath